retatrutide triple agonist gip glp-1 glucagon phase 3 2025 Eli Lilly's shows promising weight loss results in trial Retatrutide Explained: How the Triple
Description
SHAKE WELL BEFORE USING
Fair editorial context for readers
Conclusions GLP-1RA demonstrated phenotype-specific benefits, improving structural remodeling in HFpEF but showing limited effects in HFrEF
Serena Williams recently shared that she started taking the GLP-1 drug Zepbound after having her two children
